V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290007292 | 290005613 | 1.74 | 0 | Palliative (P) | 2017-07-10 | 2017-07-10 | Capecitabine | 02 | N | 290013573 | CAPECITABINE + IRINOTECAN |
| 290007293 | 290005614 | 0 | 61.8 | Palliative (P) | 2018-02-25 | 2018-02-26 | Carboplatin AUC 6 - 10 | 02 | null | 290013573 | CAPECITABINE + CISPLATIN |
| 290007294 | 290005615 | 1.86 | 82 | Curative (C) | null | 2017-11-26 | EOX | N | null | 290014208 | CETUXIMAB |
| 290007295 | 290005616 | 1.52 | 53 | null | 2019-01-15 | 2019-02-10 | Capecitabine | N | Y | 290014217 | CAPECITABINE + MITOMYCIN |
| 290007296 | 290005617 | 1.6 | 80.8 | Palliative (P) | 2017-09-13 | 2017-09-13 | CETUXIMAB + RT | Y | null | 290014291 | CAPECITABINE + OXALIPLATIN |
| 290007297 | 290005618 | 1.88 | null | Curative (C) | 2017-08-03 | 2017-08-03 | Sunitinib | N | null | 290014538 | SUNITINIB |
| 290007298 | 290005618 | 1.66 | 73.1 | Palliative (P) | 2019-03-30 | 2019-04-13 | LANREOTIDE | N | N | 290014538 | INTERAACT TRIAL |
| 290007299 | 290005619 | 1.52 | 62.9 | null | 2018-10-22 | 2018-11-18 | PERTUZUMAB + TRASTUZUMAB | 02 | N | 290014591 | LANREOTIDE |
| 290007300 | 290005619 | 1.6 | 51.8 | Not known (9) | 2017-06-27 | 2017-07-10 | Trastuzumab Subcutaneous | N | N | 290014591 | RITUXIMAB |
| 290007301 | 290008065 | 1.75 | 69.45 | Palliative (P) | 2016-09-04 | 2016-09-18 | Capecitabine 35days + RT | N | N | 290015077 | CISPLATIN + FLUOROURACIL + RT |
| 290007302 | 290005621 | 1.77 | 100.5 | Palliative (P) | 2014-02-08 | 2014-02-13 | PEMBROLIZUMAB | N | N | 290015201 | REGORAFENIB |
| 290007303 | 290005627 | null | 60.4 | Palliative (P) | 2013-11-12 | 2013-11-12 | Ralitrexed | 02 | N | 290015274 | CAPECITABINE |
| 290007304 | 290005628 | 1.78 | 66.6 | Curative (C) | 2014-09-10 | 2014-09-28 | LANREOTIDE | N | N | 290015282 | ETOPOSIDE + IFOSFAMIDE |
| 290007305 | 290005628 | null | 56.2 | Palliative (P) | 2018-11-15 | 2018-11-15 | FLUOROURACIL + MITOMYCIN | N | N | 290015282 | OXALIPLATIN + MDG + PANITUMUMAB |
| 290007306 | 290005628 | 1.76 | 67 | Disease modification (D) | 2017-07-12 | 2017-07-12 | CAPECITABINE + MITOMYCIN + RT | 02 | N | 290015282 | LANREOTIDE |
| 290007307 | 290005630 | 1.73 | 69 | Adjuvant (A) | null | 2017-05-17 | Sunitinib | 02 | N | 290015867 | CISPLATIN + RT |
| 290007308 | 290005631 | 1.47 | null | Adjuvant (A) | 2016-11-22 | 2016-12-31 | Capecitabine + Mitomycin | N | null | 290015910 | SUNITINIB |
| 290007309 | 290005632 | null | 54.5 | Curative (C) | 2015-12-06 | 2015-12-26 | Cisplatin 100 + RT(H&N) 1 day | N | N | 290015924 | CAPECITABINE + RT |
| 290007310 | 290005633 | 0 | 99.9 | Adjuvant (A) | 2014-07-17 | 2014-07-28 | CVP R | N | Y | 290016352 | CAPECITABINE |
| 290007311 | 290005633 | 1.68 | 71.8 | Disease modification (D) | 2019-08-22 | 2019-08-25 | CISPLATIN + RT | N | N | 290016352 | LANREOTIDE |
| 290007312 | 290005633 | 1.61 | 95 | Palliative (P) | null | 2015-01-22 | Carboplatin + Etoposide iv&po | N | N | 290016352 | EVEROLIMUS |
| 290007313 | 290005633 | 1.84 | 90.3 | Palliative (P) | 2016-06-16 | 2016-06-24 | LANREOTIDE | N | N | 290016352 | CAPECITABINE + IRINOTECAN |
| 290007314 | 290005634 | 1.81 | 109 | Palliative (P) | 2014-01-26 | 2014-02-26 | Capecitabine + Oxaliplatin 21day | N | N | 290016674 | CAPECITABINE + CARBOPLATIN |
| 290007315 | 290005634 | 1.85 | 58 | Curative (C) | 2018-03-05 | 2018-05-22 | EOX | 02 | Y | 290016674 | CAPECITABINE + OXALIPLATIN |
| 290007316 | 290005635 | null | 75.5 | Palliative (P) | 2019-02-02 | 2019-03-30 | Capecitabine (14 days)+Carboplatin | Y | N | 290017317 | CAPECITABINE + CISPLATIN |
| 290007317 | 290005636 | 1.7 | 83 | Neo-adjuvant (N) | 2018-07-02 | 2018-07-09 | Cisplatin + Radiotherapy | N | N | 290017352 | CAPECITABINE + OXALIPLATIN |
| 290007318 | 290005637 | 1.6 | 76.05 | Palliative (P) | null | 2017-04-03 | Cisplatin 100 + RT(H&N) 1 day | null | null | 290017365 | CARBOPLATIN + ETOPOSIDE |
| 290007319 | 290007395 | 1.59 | 75.5 | Neo-adjuvant (N) | 2013-08-05 | 2013-08-05 | CARBOPLATIN + PACLITAXEL | N | N | 290017510 | CISPLATIN + FLUOROURACIL + RT |
| 290007320 | 290005638 | 1.79 | 108 | Palliative (P) | 2016-04-24 | 2016-04-29 | Capecitabine + Cisplatin | N | N | 290017510 | TRIAL |
| 290007321 | 290007398 | 1.86 | null | Palliative (P) | 2016-03-05 | 2016-03-06 | Trial Unspecified | null | Y | 290018262 | LANREOTIDE |
| 290007322 | 290005641 | 1.6 | 58 | Curative (C) | 2018-09-07 | 2018-11-17 | Cetuximab +Cisplatin + FU (Cycle 1) | N | N | 290018375 | MITOMYCIN |
| 290007323 | 290005642 | 1.75 | null | Palliative (P) | 2016-05-22 | 2017-11-21 | PACLITAXEL | N | N | 290018498 | CAPECITABINE + CARBOPLATIN |
| 290007324 | 290005643 | 1.78 | 75 | null | 2018-02-02 | 2018-02-02 | Trial Unspecified | 02 | N | 290018498 | LANREOTIDE |
| 290007325 | 290005643 | null | 76 | Palliative (P) | 2018-09-24 | 2018-10-03 | FLUOROURACIL + MITOMYCIN | N | N | 290018498 | CAPECITABINE + IRINOTECAN |
| 290007326 | 290005644 | 1.58 | 76 | Palliative (P) | 2018-01-27 | 2018-02-10 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 290019430 | CARBOPLATIN + CETUXIMAB + FU |
| 290007327 | 290005645 | null | 65 | Adjuvant (A) | 2018-08-22 | 2018-08-27 | LANREOTIDE | 02 | N | 290019493 | TRASTUZUMAB |
| 290007328 | 290005646 | 1.61 | null | Palliative (P) | 2014-06-15 | 2014-06-21 | Irinotecan 14day | N | N | 290019536 | CISPLATIN + GEMCITABINE |
| 290007329 | 290005647 | 1.68 | 43 | Curative (C) | 2018-05-08 | 2018-05-26 | Docetaxel | 02 | Y | 290019536 | FLUOROURACIL + MITOMYCIN |
| 290007330 | 290005647 | null | null | null | 2018-02-20 | 2018-02-27 | CISPLATIN + RT | N | N | 290019536 | CARBOPLATIN + ETOPOSIDE |
| 290007331 | 290005649 | 1.69 | 81.6 | Palliative (P) | 2018-11-15 | 2018-11-23 | MCX | N | N | 290019677 | CAPECITABINE + CISPLATIN |
| 290007332 | 290007402 | 1.58 | null | Adjuvant (A) | 2018-10-05 | 2018-10-12 | CETUXIMAB + RT | 02 | N | 290019747 | CISPLATIN + RT |
| 290007333 | 290005650 | 1.73 | 98 | Palliative (P) | 2016-10-01 | 2016-10-06 | LANREOTIDE | 02 | N | 290020171 | PACLITAXEL |
| 290007334 | 290005652 | 1.5 | 71.6 | Curative (C) | 2019-07-27 | 2019-07-27 | CAPECITABINE + MITOMYCIN + RT | 2 | N | 290020300 | CISPLATIN + RT |
| 290007335 | 290005653 | null | 55.6 | Palliative (P) | 2018-06-17 | 2018-06-28 | Capecitabine + Oxaliplatin 21day | 02 | N | 290020320 | CETUXIMAB + CISPLATIN + FU |
| 290007336 | 290007403 | 0 | 48.9 | Adjuvant (A) | 2013-05-03 | 2013-05-03 | Capecitabine | 02 | N | 290020387 | CISPLATIN + RT |
| 290007337 | 290005654 | 1.71 | null | Palliative (P) | 2015-08-02 | 2015-08-02 | Capecitabine | 02 | N | 290020477 | CARBOPLATIN + ETOPOSIDE |
| 290007338 | 290007404 | null | 69.2 | null | 2017-10-30 | 2017-11-08 | EVEROLIMUS | N | N | 290020477 | FLUOROURACIL + MITOMYCIN |
| 290007339 | 290007405 | 1.68 | 88.4 | Neo-adjuvant (N) | null | 2016-06-23 | Fluorouracil PVI + Mitomycin 21day | N | N | 290020686 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290007340 | 290005656 | 1.78 | 81 | Palliative (P) | 2018-12-06 | 2018-12-06 | MITOMYCIN | N | N | 290020732 | EVEROLIMUS |
| 290007341 | 290005658 | 1.76 | null | Neo-adjuvant (N) | 2016-05-19 | 2016-05-19 | Capecitabine | N | N | 290020732 | CISPLATIN + DOCETAXEL + FLUOROURACIL |